• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的手术考量

Surgical considerations in ovarian cancer.

作者信息

Cohen C J

出版信息

Semin Oncol. 1985 Sep;12(3 Suppl 4):53-6.

PMID:4048977
Abstract

A primary consideration for effective management of ovarian cancer is distinguishing patients with advanced bulky disease from those with other stages of disease. It is important to determine whether a tumor is confined to one ovary or is more wide-spread. Surgical management includes removal of both ovaries and tubes, the uterus, omentum, and bulk of the disease. The degree of bulk reduction achieved significantly impacts on survival. Conservation is justified in some cases. Intraperitoneal treatment with platinum-based chemotherapy postsurgery appears to substantially benefit patients with minimal residual disease. In a study comparing two catheter methods, fewer complications were noted with the disposable single-use catheter than with the implanted catheter. Surgical endstaging can definitively identify cured patients. However, it is a difficult procedure and is contraindicated in patients with severe intercurrent illness, previous extensive radiotherapy, and an obliterated peritoneal cavity.

摘要

有效管理卵巢癌的一个主要考虑因素是区分患有晚期大块疾病的患者与患有其他疾病阶段的患者。确定肿瘤是局限于一个卵巢还是扩散得更广很重要。手术管理包括切除双侧卵巢和输卵管、子宫、大网膜以及大部分病灶。实现的减瘤程度对生存率有显著影响。在某些情况下,保留是合理的。术后腹腔内使用铂类化疗似乎能使残留疾病最少的患者受益匪浅。在一项比较两种导管方法的研究中,一次性使用导管的并发症比植入式导管少。手术分期可以明确识别治愈的患者。然而,这是一个困难的手术,在患有严重并发疾病、先前接受过广泛放疗以及腹膜腔闭塞的患者中是禁忌的。

相似文献

1
Surgical considerations in ovarian cancer.卵巢癌的手术考量
Semin Oncol. 1985 Sep;12(3 Suppl 4):53-6.
2
Experimental and clinical results with intraperitoneal cisplatin.腹腔内顺铂的实验与临床结果
Semin Oncol. 1985 Sep;12(3 Suppl 4):43-6.
3
The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.格罗雄导管作为一种用于治疗卵巢癌患者的腹腔内通路装置。
Gynecol Oncol. 1993 Sep;50(3):291-3. doi: 10.1006/gyno.1993.1213.
4
Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.腹腔内顺铂和静脉注射紫杉醇治疗二次探查阳性的上皮性卵巢癌患者
Gynecol Oncol. 2000 Oct;79(1):28-32. doi: 10.1006/gyno.2000.5890.
5
Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:354-8.
6
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.在III期卵巢癌和原发性腹膜癌最佳分期患者中静脉化疗与腹腔化疗对比试验的腹腔导管结局:一项妇科肿瘤学组研究
Gynecol Oncol. 2006 Jan;100(1):27-32. doi: 10.1016/j.ygyno.2005.11.013.
7
Intraperitoneal chemotherapy in the management of ovarian cancer.腹腔内化疗在卵巢癌治疗中的应用
Semin Oncol. 1985 Sep;12(3 Suppl 4):75-80.
8
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.顺铂与5-氟尿嘧啶腹腔内联合用药治疗晚期卵巢癌既往治疗患者的II期试验:长期随访
Gynecol Oncol. 2000 Jun;77(3):433-8. doi: 10.1006/gyno.2000.5793.
9
The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.全面手术分期在早期上皮性卵巢癌治疗中的益处。
Gynecol Oncol. 2002 May;85(2):351-5. doi: 10.1006/gyno.2002.6636.
10
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.顺铂和紫杉醇腹腔内给药治疗卵巢癌
N Engl J Med. 2006 Jan 5;354(1):34-43. doi: 10.1056/NEJMoa052985.

引用本文的文献

1
Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases.
Ann Surg Oncol. 1996 Jan;3(1):44-50. doi: 10.1007/BF02409050.
2
Kinetic resistance to anticancer agents.抗癌药物的动力学耐药性。
Cytotechnology. 1993;12(1-3):347-56. doi: 10.1007/BF00744672.